FMP
T. Rowe Price Health Sciences Fund I Class
THISX
NASDAQ
The investment seeks long-term capital appreciation. The fund will normally invest at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies.
89.75 USD
-0.52 (-0.579%)
About
ceo
N/A
sector
Financial Services
industry
Asset Management
website
N/A
exchange
NASDAQ
Description
The investment seeks long-term capital appreciation. The fund will normally invest at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies.
CIK
0001002624
ISIN
US87281Y1029
CUSIP
87281Y102
Address
T. Rowe Price Health Sciences ...
Phone
800-638-8790
Country
US
Employee
N/A
IPO Date
Mar 24, 2016
Summary
CIK
0001002624
Exchange
NASDAQ
Industry
Asset Management
Sector
Financial Services
CUSIP
87281Y102
ISIN
US87281Y1029
Country
US
Price
89.75
Beta
0.73
Volume Avg.
0
Market Cap
14.56B
Shares
-
52-Week
81.63-95.74
DCF
0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
3.93
P/B
-
Website
-
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest THISX News
It looks like there's no news available.
